Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis.
about
Roles of IL-33 in Resistance and Tolerance to Systemic Candida albicans InfectionsNatural Killer Cells and Liver FibrosisMacrophage and Innate Lymphoid Cell Interplay in the Genesis of FibrosisInterleukin-1 Family Cytokines in Liver DiseasesInnate Immunity and Biomaterials at the Nexus: Friends or FoesRemodelling the extracellular matrix in development and diseasePathogenesis of biliary atresia: defining biology to understand clinical phenotypesGroup 2 innate lymphoid cells in the lungInnate lymphoid cells, possible interaction with microbiotaExternalized decondensed neutrophil chromatin occludes pancreatic ducts and drives pancreatitisGalectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitisCrosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor MicroenvironmentNKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in miceThe ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases.Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation.Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling.Full Length Interleukin 33 Aggravates Radiation-Induced Skin Reaction.Establishment and function of tissue-resident innate lymphoid cells in the skin.TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis.Interleukins in chronic liver disease: lessons learned from experimental mouse modelsThe interleukin-1 family: back to the futureIL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells.Hepatic inflammation and fibrosis: functional links and key pathways.Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunologyInterleukin-33 in Tissue Homeostasis, Injury, and InflammationCell death and cell death responses in liver disease: mechanisms and clinical relevanceEarly Persistent Blood Eosinophilia in Necrotizing Enterocolitis Is a Predictor of Late Complications.Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis.Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population with Stricturing Crohn's Ileitis.Inflammatory group 2 innate lymphoid cells.Expansion of CD25+ Innate Lymphoid Cells Reduces AtherosclerosisIL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing.Genome-wide analysis of DNA methylation and gene expression defines molecular characteristics of Crohn's disease-associated fibrosis.Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair.IL-33 Contributes to Schistosoma japonicum-induced Hepatic Pathology through Induction of M2 MacrophagesPeri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.Regulation of metabolic health and adipose tissue function by group 2 innate lymphoid cellsEmerging concepts and future challenges in innate lymphoid cell biologyIL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
P2860
Q26747318-AE8B92EF-C1C2-416E-9FCD-D00D1196C4A4Q26767448-CC9CBEB9-B769-4AC6-8270-537A7000EDD5Q26774652-3ABCC836-94E3-4E5F-AEC9-8A6985933A1AQ26778553-31845B47-E34F-4447-99C0-CDC88C70AD33Q26801604-0E8C8E56-CBC5-4730-B5C6-0CFC039E5782Q26864798-A92C0E40-14EB-489B-9873-B4FEF295BFF4Q27006535-1F9D10DD-4864-4196-AFC5-A4441B1FA604Q27021302-929BCA39-9E1E-41CB-8FD7-C2D693A87015Q27026229-64B26C93-B46C-4A56-9BAF-589225C5BB02Q27324281-C75A2856-ED4F-4801-89B3-A98233A0DCD1Q28069174-31AD7227-F25A-4BF9-A8BB-C10C49A75479Q28077126-E5AE9AE3-177D-4F1F-A67F-C4156E84CB32Q30277911-05E5F25B-AD52-4117-8534-846A3006A31EQ33593742-E899B3FD-EDCD-47EE-BB88-C94CBB333111Q33790954-5280B302-BDB3-420F-B15B-4C479472DEBAQ33808159-F9FD98C1-AE33-4641-B562-10D613522283Q33822409-37C637D9-3196-40EE-8A2E-7C912D8E850AQ33843062-83225760-E0A2-4752-8175-DCE9A2AA5615Q33874975-A830DD2C-1E85-4B4F-A451-76A7D90D126FQ33912038-10D6480F-ADD6-4871-B833-B57E5FCEA61EQ34154258-1FC8B5BC-12AC-4EF2-8FA4-DBE11120575CQ34391415-65DCC905-8D6D-46D1-B166-A7F22C59514AQ34979676-4AC32C95-FD92-4A01-B1FD-7C204DD29930Q35213917-E54E863A-9AE6-44F5-AAD4-FB45263E0BB7Q35638915-B59D108D-9EA4-43A9-B81D-461601C23C1EQ35754479-92BE955F-FB93-4731-AE7C-036F6F11B79EQ35938040-FDF80DDF-E024-4E7E-8A94-E4857D6E0F4EQ35967497-112ECB27-FB9F-431B-A94A-39BDBBEE7828Q36025690-795EABA2-11BD-4412-8A2D-34694E7814D1Q36053010-47EA82F8-8937-4F41-968C-1BBF70722063Q36468792-4B8956DD-A582-4451-BBC4-247335FE2A66Q36475881-62C23507-7C74-4BA2-B054-13A989B4790AQ36514695-659C039E-10BC-4539-8D64-653A0946D87CQ36680459-9CE211EE-37AD-4C4F-AAB6-0D1981597520Q36687542-EF922669-7998-4FDB-80AB-95F7108F4CDEQ37116617-F5A9A914-44DC-4AF1-AB73-A815869B925AQ37117633-F8ECF5E5-C9A1-4E83-BE3E-CB5EC006ACB4Q37313634-03D5B905-3AFB-4F13-BBE0-ED0891BC586EQ37346684-48EA64D5-02F6-4DC0-A227-F739EC4672D5Q37376114-6028FC69-7C9B-42AA-8CA6-84367CDEF270
P2860
Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis.
@en
type
label
Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis.
@en
prefLabel
Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis.
@en
P2093
P2860
P1433
P1476
Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis.
@en
P2093
Andrew L Rankin
David Voehringer
Jennifer Walker
Marcus Schuchmann
Markus F Neurath
Maximilian Waldner
Stefan Pflanz
Steffen Zopf
Tamar McHedlidze
P2860
P304
P356
10.1016/J.IMMUNI.2013.07.018
P407
P577
2013-08-15T00:00:00Z